Brace yourselves and prepare to be inspired by four unique and inspiring personalities of the Medicine and Scientific World. Adding up to our three futuristic modules, these talks will broaden your horizons unravelling some of the most hot topics of today such as: Space Medicine, Immortality and the Cure of some deadly chronic diseases. You will also be able to learn from the best by witnessing a lifelong passion and dedication to science at our Nobel Lecture.

Sir Tim Hunt, PhD

PhD degree at Cambridge University; Nobel Prize in Physiology or Medicine (2001); Member of the European Molecular Biology Organization (EMBO); Fellow of the Royal Society; Fellow of the Academy of Medical Sciences (FMedSci); Associate of the National Academy of Sciences; Honorary Fellow of the Royal Society of Edinburgh; Royal Society‘s Royal Medal; Night Bachelor; member of the Scientific Council of the European Research Council (ERC); Emeritus Group Leader at the Francis Crick Institute.

Professor Sir Tim Hunt is a british biochemist known for his pioneering research in the regulation of cell cycle. Prof. Hunt completed his PhD at Biochemistry Department of University of Cambridge, focusing on “The Synthesis of Haemoglobin”. During his early career, while working on the Marine Biological Laboratory (Massachusetts), while studying the sea urchin lead to the discovery of the cyclin – the regulatory protein of cell division. In 1990, Prof. Hunt became a principal investigator at Imperial Cancer Research Fund, focusing on the uncontrolled proliferation of cancer cells. He also became an Emeritus Group Leader at the Francis Crick Institute. In 2001, for his innovative research, Sir Tim Hunt was awarded with the Nobel Prize in Physiology or Medicine. His work has been extensively recognized by international awards as the  Royal Society’s Royal Medal; Honorary fellow of the Royal Society of Edinburgh and fellow of the Academy of Medical Sciences.

Scott Parazynski, MD

MD degree at Stanford University School of Medicine; United States Astronaut Hall of Fame; CEO of Fluidity Technologies.


Dr. Scott Parazynski is a highly decorated and experienced Astronaut, Spacewalker, Physician, Entrepreneur and Product Developer. Having started has a medical student at Stanford University School of Medicine, his life has passed through management, space, technology, writing and adventure. After finishing his medical residency in the Department of Emergency Medicine in various Denver hospitals in 1992, Dr. Parazynski entered NASA where, after 16 years of affiliation, 5 outer-space missions and 7 space-walks, entered the United States Astronaut Hall of Fame in 2016. Dr. Parazynski served crewmate and personal physician of John Glenn, the first north-american to orbit Earth. Amongst his most iconic explorations we can find: summiting the Mount Everest, rapelling to the “shoreline” of Masaya volcano’s lava lake, and free diving into the summit caldera lake atop Licancabur, one of the world’s highest. In 2016, Dr. Scott founded Fluidity Technologies, focused on the development of revolutionary input devices powered by machine learning to intuitively move through physical and virtual space. In 2017, The Sky Below, his first and yet only book about all his accomplishments was released.

Nir Barzilai

Director of the Institute of Aging Research at the Albert Einstein College of Medicine; Director of the Paul F. Glenn Center for the Biology of Human Aging Research; Director of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging; Co-scientific director of the American Federation for Aging Research; Founder of CohBar Inc.; Awarded by the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Paul F. Glenn Foundation Award, the NIA Nathan Shock Award, and the 2010 Irving S. Wright Award of Distinction in Aging Research. 


Nir Barzilai is the director of the Institute of Aging Research at the Albert Einstein College of Medicine. His pioneer work focuses on the genetics of aging. By thoroughly analyzing families with exceptional longevity, Dr. Barzilai studies protective genes in aging and their protection against age-related diseases in the Longevity Genes Project he helds at Algert Einstein College of Medicine. He is currently leading an international effort to approve drugs targeting aging. Targeting Aging with METformin (TAME) is a study designed to prove that multi-morbidities of aging can be delayed by metformin, serving as an example for future efforts to delay aging and its diseases in humans. His discoveries have been influencing treatments of type 2 diabetes. He is also a founder of CohBar Inc., a biotech that develops mitochondrial derived peptides as therapy for aging and its diseases. He has been recognized by numerous awards like of the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award and published over 230 peer-reviewed papers, reviews, and textbook chapters.

Nezam Afdhal, MD

MD degree at the Royal College of Surgeons in Ireland; Chief of Hepatology and director of the Liver Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts; Professor of Medicine at Harvard Medical School.


Dr. Afdhal has been named in 2019 Chief of the Division of Gastroenterology, Hepatology and Nutrition at Beth Israel Deaconess Medical Center (BIDMC). His efforts have been immense in the understanding of a series of liver diseases mostly labelled as uncurable. While being a director of various clinical trials for novel treatments of hepatitis B and C, liver fibrosis and NASH, his contribution to improving patients’ lives have been undeniable in Hepatology. Not only has Dr. Afdhal published more than 250 original manuscripts, reviews and editorials, featuring in the New England Journal of Medicine, the Journal of Hepatology and other respected journals; but also is the editor of the Journal of Viral Hepatitis. Amongst his multiple awards we can highlight the American Liver Foundation Award for Excellence. Dr. Nezam is found as a member of the American Gastroenterological Association, the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.